Meddata maintains a narrowly scoped portfolio centered on its HBYS healthcare management application, which operates in a specialized vertical where data-handling reliability is critical. The recurring signal across its vulnerability disclosures centers on SQL injection and improper neutralization of special elements in database queries, reflecting input-validation challenges common to data-driven healthcare applications. Current severity, exploitation activity, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Meddata over time
Signals from CVEs in this vendor scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2021-43361CRITICAL Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in MedData HBYS allows SQL Injection.This issue affects HBYS: from unspecified be | Nov 16, 2021 | 9.8 | 30 | NO | NO |
CVE-2021-43362CRITICAL Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection') vulnerability in MedData HBYS allows SQL Injection.This issue affects HBYS: from unspecified be | Nov 16, 2021 | 9.8 | 29 | NO | NO |
Signals from CVEs in this vendor scope (2 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Meddata.
Media articles that mention a CVE ID that affects a product developed by Meddata — matched by CVE ID, not by vendor name.